Health Products

Cellex Photopheresis System (2018-08-10)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesModel or catalog number
Software Version 3.0Cellex Photopheresis System
Manufacturer
Therakos Inc.
10 North High Street, Suite 300
West Chester
19380
Pennsylvania
UNITED STATES
CELLEX

Introduction

Affected products

Cellex Photopheresis System

Reason

Mallinckrodt has received reports of thromboembolic events associated with the use of the THERAKOS CELLEX Photopheresis System in the treatment of Graft versus Host Disease (GvHD). Patients with GvHD have an increased risk of thromboembolic events. The Caution Statement will be updated in the device Operator's Manual section, titled "Anticoagulation."
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime